ArticleThe Journal of clinical investigation2020

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.

Vanessa Gauttier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.